Hilbert M. Branderhorst
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hilbert M. Branderhorst.
ChemBioChem | 2008
Hilbert M. Branderhorst; Rob Ruijtenbeek; Rob M. J. Liskamp; Roland J. Pieters
Dendrimers were fitted out with up to eight mannose moieties by “click” chemistry. They were subsequently attached to aluminum oxide chips via a spacer that was linked to the dendrimer core; this resulted in a microarray of glycodendrimers. Binding of the glycodendrimers to the fluorescent lectins ConA and GNA was observable in real time. In a single experiment it was possible to observe the multivalency enhancement or cluster effect in the binding event. This effect was small for ConA, in agreement with its widely spaced binding sites, whereas it was large for GNA, with its twelve much more closely spaced binding sites. The dendrimer‐fitted chip represents a valuable screening tool for multivalency effects. Furthermore kinetic and thermodynamic data on binding events can be deduced. Inhibition experiments are also possible with the system as was shown for ConA with α‐methyl mannose as the inhibitor.
ChemBioChem | 2009
Cristina Sisu; Andrew J. Baron; Hilbert M. Branderhorst; Simon D. Connell; Carel A. G. M. Weijers; Renko de Vries; Edward D. Hayes; Aliaksei V. Pukin; Michel Gilbert; Roland J. Pieters; Han Zuilhof; Gerben M. Visser; W. Bruce Turnbull
Divalent and tetravalent analogues of ganglioside GM1 are potent inhibitors of cholera toxin and Escherichia coli heat‐labile toxin. However, they show little increase in inherent affinity when compared to the corresponding monovalent carbohydrate ligand. Analytical ultracentrifugation and dynamic light scattering have been used to demonstrate that the multivalent inhibitors induce protein aggregation and the formation of space‐filling networks. This aggregation process appears to arise when using ligands that do not match the valency of the protein receptor. While it is generally accepted that multivalency is an effective strategy for increasing the activity of inhibitors, here we show that the valency of the inhibitor also has a dramatic effect on the kinetics of aggregation and the stability of intermediate protein complexes. Structural studies employing atomic force microscopy have revealed that a divalent inhibitor induces head‐to‐head dimerization of the protein toxin en route to higher aggregates.
ChemBioChem | 2010
Núria Parera Pera; Hilbert M. Branderhorst; Raymond Kooij; Caroline Maierhofer; Marjolein van der Kaaden; Rob M. J. Liskamp; Valentin Wittmann; Rob Ruijtenbeek; Roland J. Pieters
Multivalency is an important phenomenon in protein–carbohydrate interactions. In order to evaluate glycodendrimers as multivalent inhibitors of carbohydrate binding proteins, we displayed them on a microarray surface. Valencies were varied from 1 to 8, and corrections were made for the valencies so that all surfaces contained the same amount of the sugar ligand. Five different carbohydrates were attached to the dendrimers. A series of fluorescent lectins was evaluated, and for each of them a binding profile was obtained from a single experiment showing both the specificity of the lectin for a certain sugar and whether it prefers multivalent ligands or not. Very distinct binding patterns were seen for the various lectins. The results were rationalized with respect to the interbinding distances of the lectins.
Organic and Biomolecular Chemistry | 2010
Núria Parera Pera; Annika Kouki; Sauli Haataja; Hilbert M. Branderhorst; Rob M. J. Liskamp; Gerben M. Visser; Jukka Finne; Roland J. Pieters
Detection of the zoonotic bacterial pathogen Streptococcus suis was achieved using magnetic glycoparticles. The bacteria contain an adhesion protein for the carbohydrate sequence Galalpha1,4Gal. After incubation with various amounts of the pathogen, magnetic concentration and ATP detection, bacterial levels down to 10(5) cfu could be detected. Submicrometer particles were needed, since with the larger microparticles the method did not succeed.
Journal of Medicinal Chemistry | 2013
Hilde van Hattum; Hilbert M. Branderhorst; Ed E. Moret; Ulf J. Nilsson; Hakon Leffler; Roland J. Pieters
Inhibitors for galectin-1 and -3 were synthesized from thiodigalactoside and lactosamine by derivatization of the galactose C3. Introduction of 4-phenyl-1H-1,2,3-triazol-1-yl substituents at the thiodigalactoside C3 by CuAAC, targeting arginine-arene interactions, increased the affinity to 13 nM but yielded little selectivity. The bulkier 4-(4-phenoxyphenyl)-1H-1,2,3-triazol-1-yl substituent, however, increased the preference for galectin-3 over galectin-1 to more than 200-fold. Modeling showed more arginine-arene interactions for galectin-3 than for galectin-1. Introducing 4-phenoxyaryl groups on lactosamine had a similar effect.
MedChemComm | 2013
Raymond Kooij; Hilbert M. Branderhorst; Simon Bonte; Wieclawska Sm; Nathaniel I. Martin; Roland J. Pieters
Novel guanidinium and urea derivatives of 1-deoxynojirimycin were prepared using a concise synthetic protocol and tested against a panel of glycosidases for their inhibitory properties. Potent and selective inhibition was observed with both classes of compounds. Further investigation involving an expanded series of NG-substituted guanidinium deoxynojirimycin analogues revealed distinct inhibitory profiles in the inhibition of the glycosidases tested.
Tetrahedron Letters | 2002
Hilbert M. Branderhorst; Johan Kemmink; Rob M. J. Liskamp; Roland J. Pieters
Catalytic diazo decomposition chemistry was explored with novel diazoacetate functionalized carbohydrates. In both glucose and galactose derivatives, aromatic cycloadditions with the benzyl protecting groups proved to be most favorable reactions. Replacing the benzyl groups by methoxy groups in the glucose system led to formation of ‘carbene dimers’.
Bioorganic & Medicinal Chemistry Letters | 2009
H. Bauke Albada; Christopher J. Arnusch; Hilbert M. Branderhorst; Anne-Marie Verel; Wouter T.M. Janssen; Eefjan Breukink; Ben de Kruijff; Roland J. Pieters; Rob M. J. Liskamp
The antibiotic vancomycin-that binds lipid II in the bacterial cell membrane-was conjugated to a mono- and tetravalent mimic of the tris-histidine catalytic triad of metalloenzymes. Targeted hydrolysis by the conjugate was observed using model membranes containing lipid II, and in vitro MIC-values of the targeted mimic constructs could be modulated by Zn-ions.
Biology | 2013
Roland J. Pieters; Hans-Christian Slotved; Hanne Møller Mortensen; Jukka Finne; Sauli Haataja; John A. F. Joosten; Hilbert M. Branderhorst; Karen A. Krogfelt
Streptococcus suis is an important swine pathogen associated with a variety of infections such as meningitis, arthritis and septicemia. The bacterium is zoonotic and has been found to cause meningitis especially in humans occupationally exposed to infected pigs. Since adhesion is a prerequisite for colonization and subsequent infection, anti-adhesion treatment seems a natural alternative to traditional treatment with antibiotics. In order to optimize the inhibitory potency a multivalency approach was taken in the inhibitor design. A synthetic tetravalent galabiose compound was chosen which had previously shown promising anti-adhesion effects with S. suis in vitro. The aim of this study was to evaluate the in vivo effects of the compound using an infection peritonitis mouse model. As such S. suis serotype 2 infection and treatment were tested in vivo and the effects were compared to the effect of treatment with penicillin.
ChemBioChem | 2007
Aliaksei V. Pukin; Hilbert M. Branderhorst; Cristina Sisu; Carel A. G. M. Weijers; Michel Gilbert; Rob M. J. Liskamp; Gerben M. Visser; Han Zuilhof; Roland J. Pieters